Personalized Clinical Approaches to Anxiety Disorders

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works

The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions

Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615 · see citing works

Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection

Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741 · see citing works

Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States

Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947 · see citing works

Epidemiology of anxiety disorders in the 21st century

Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079 · see citing works

Biological Bases of Childhood Shyness

Kagan, J., Reznick, J. S., & Snidman, N. (1988) · Science · doi:10.1126/science.3353713 · Cited by 1,577 · see citing works

Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis

Chalmers, J. A., Quintana, D. S., Abbott, M. J.-A., & Kemp, A. H. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00080 · Cited by 1,067 · see citing works

Neuroanatomical Hypothesis of Panic Disorder, Revised

Gorman, J. M., KENT, J. M., Sullivan, G. M., & Coplan, J. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.493 · Cited by 998 · see citing works

Treatment of anxiety disorders

Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811 · see citing works

Amygdala and Ventrolateral Prefrontal Cortex Activation to Masked Angry Faces in Children and Adolescents With Generalized Anxiety Disorder

Monk, C. S., Telzer, E. H., Mogg, K., Bradley, B. P., Mai, X., Louro, H. M. C., Chen, G., McClure-Tone, E. B., Ernst, M., & Pine, D. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.568 · Cited by 682 · see citing works

Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis

Mayo-Wilson, E., Dias, S., Mavranezouli, I., Kew, K., Clark, D. M., Ades, A. E., & Pilling, S. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70329-3 · Cited by 680 · see citing works

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676 · see citing works

Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder

Etkin, A., Prater, K. E., Schatzberg, A. F., Menon, V., & Greicius, M. D. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.104 · Cited by 664 · see citing works

Behavioral Inhibition and Risk for Developing Social Anxiety Disorder: A Meta-Analytic Study

Clauss, J. A., & Blackford, J. U. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.08.002 · Cited by 573 · see citing works

Human and economic burden of generalized anxiety disorder

Hoffman, D. L., Dukes, E. M., & Wittchen, H.-U. (2008) · Depression and Anxiety · doi:10.1002/da.20257 · Cited by 438 · see citing works

Abnormal attention modulation of fear circuit function in pediatric generalized anxiety disorder

McClure, E. B., Monk, C. S., Nelson, E. E., Parrish, J. M., Adler, A., Blair, R. J. R., Fromm, S., Charney, D. S., Leibenluft, E., Ernst, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.97 · Cited by 431 · see citing works

The etiology of social anxiety disorder: An evidence-based model.

Spence, S., & Rapee, R. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.06.007 · Cited by 426 · see citing works

Anticipatory Activation in the Amygdala and Anterior Cingulate in Generalized Anxiety Disorder and Prediction of Treatment Response

Nitschke, J. B., Sarinopoulos, I., Oathes, D. J., Johnstone, T., Whalen, P. J., Davidson, R. J., & Kalin, N. H. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07101682 · Cited by 375 · see citing works

A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder

Guastella, A. J., Howard, A. L., Dadds, M. R., Mitchell, P., & Carson, D. S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.01.005 · Cited by 366 · see citing works

Remission in CBT for adult anxiety disorders: A meta-analysis

Springer, K. S., Levy, H. C., & Tolin, D. F. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.03.002 · Cited by 364 · see citing works

Fear and panic in humans with bilateral amygdala damage

Feinstein, J. S., Buzza, C., Hurlemann, R., Follmer, R. L., Dahdaleh, N. S., Coryell, W. H., Welsh, M. J., Tranel, D., & Wemmie, J. A. (2013) · Nature Neuroscience · doi:10.1038/nn.3323 · Cited by 350 · see citing works

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190867 · Cited by 347 · see citing works

Meta-Analysis of Anxiety as a Risk Factor for Cardiovascular Disease

Emdin, C. A., Odutayo, A., Wong, C. X., Tran, J., Hsiao, A. J., & Hunn, B. H. M. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.05.041 · Cited by 329 · see citing works

Response to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders

Blair, K., Shaywitz, J., Smith, B. W., Rhodes, R., Geraci, M., Jones, M., McCaffrey, D., Vythilingam, M., Finger, E., Mondillo, K., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071060 · Cited by 282 · see citing works

Behavioral inhibition in preschool children at risk is a specific predictor of middle childhood social anxiety: a five-year follow-up

Hirshfeld-Becker, D. R., Biederman, J., Henin, A., Faraone, S. V., Davis, S., Harrington, K., & Rosenbaum, J. F. (2007) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/01.dbp.0000268559.34463.d0 · Cited by 265 · see citing works

Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.

Alonso, J., & Lépine, J. (2007) · PubMed · Cited by 227 · see citing works

Genetic and Environmental Sources of Covariation Between Generalized Anxiety Disorder and Neuroticism

Hettema, J. M., Prescott, C. A., & Kendler, K. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1581 · Cited by 224 · see citing works

Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study

Ameringen, M. A. V., Lane, R. M., Walker, J. R., Bowen, R. C., Chokka, P. R., Goldner, E. M., Johnston, D. G., Lavallée, Y.-J., Nandy, S., Pecknold, J. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.275 · Cited by 221 · see citing works

Oxytocin Levels in Social Anxiety Disorder

Hoge, E. A., Pollack, M. H., Kaufman, R. E., Zak, P. J., & Simon, N. M. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00051.x · Cited by 213 · see citing works

A Functional Magnetic Resonance Imaging Predictor of Treatment Response to Venlafaxine in Generalized Anxiety Disorder

Whalen, P. J., Johnstone, T., Somerville, L. H., Nitschke, J. B., Polis, S., Alexander, A. L., Davidson, R. J., & Kalin, N. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.019 · Cited by 210 · see citing works

Decreased hair cortisol concentrations in generalised anxiety disorder

Steudte‐Schmiedgen, S., Tobias Stalder, A., Dettenborn, L., Klumbies, E., Foley, P., Beesdo‐Baum, K., & Kirschbaum, C. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.09.002 · Cited by 207 · see citing works

Childhood trauma and current psychological functioning in adults with social anxiety disorder

Kuo, J. R., Goldin, P. R., Werner, K. H., Heimberg, R. G., & Gross, J. J. (2010) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.11.011 · Cited by 194 · see citing works

Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety

Ziegler, C., Dannlowski, U., Bräuer, D., Stevens, S., Laeger, I., Wittmann, H., Kugel, H., Dobel, C., Hurlemann, R., Reif, A., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.2 · Cited by 193 · see citing works

MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy

Ziegler, C., Richter, J., Mahr, M., Gajewska, A., Schiele, M. A., Gehrmann, A., Schmidt, B., Lesch, K.-P., Lang, T., Helbig-Lang, S., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.41 · Cited by 183 · see citing works

Localized gray matter volume abnormalities in generalized anxiety disorder

Schienle, A., Ebner, F., & Schäfer, A. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0147-5 · Cited by 163 · see citing works

Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder

Liebowitz, M. R., Gelenberg, A. J., & Munjack, D. J. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.190 · Cited by 163 · see citing works

Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder

Stein, M. B., Seedat, S., & Gelernter, J. E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0349-8 · Cited by 161 · see citing works

Meta‐analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity

Domschke, K., Deckert, J., O’Donovan, M. C., & Glatt, S. J. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30494 · Cited by 157 · see citing works

Neuroendocrine Responses to Psychological Stress in Adolescents with Anxiety Disorder

Gerra, G., Zaimovic, A., Zambelli, U., Timpano, M., Reali, N., Bernasconi, S., & Brambilla, F. (2000) · Neuropsychobiology · doi:10.1159/000026677 · Cited by 153 · see citing works

Pharmacotherapy of anxiety disorders: A critical review

Koen, N., & Stein, D. J. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/nkoen · Cited by 151 · see citing works

Salivary testosterone: Associations with depression, anxiety disorders, and antidepressant use in a large cohort study

Giltay, E. J., Enter, D., Zitman, F. G., Penninx, B. W. J. H., PELT, J. V., Spinhoven, P., & Roelofs, K. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.11.014 · Cited by 142 · see citing works

Common and disorder-specific neural responses to emotional faces in generalised anxiety, social anxiety and panic disorders

Fonzo, G. A., Ramsawh, H. J., Flagan, T. M., Sullivan, S. G., Letamendi, A., Simmons, A. N., Paulus, M. P., & Stein, M. B. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.149880 · Cited by 138 · see citing works

Oxytocin and social functioning

Jones, C., Barrera, I., Brothers, S., Ring, R., & Wahlestedt, C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/cjones · Cited by 132 · see citing works

The Neural Correlates of Social Anxiety Disorder and Response to Pharmacotherapy

Kilts, C. D., Kelsey, J. E., Knight, B. T., Ely, T. D., Bowman, F. D., Gross, R. E., Selvig, A., Gordon, A. B., Newport, D. J., & Nemeroff, C. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301053 · Cited by 128 · see citing works

The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies

Kalk, N. J., Nutt, D., & Lingford-Hughes, A. R. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367448 · Cited by 123 · see citing works

Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis

Copeland, W. E., Shanahan, L., Worthman, C., Angold, A., & Costello, E. J. (2012) · Psychological Medicine · doi:10.1017/s0033291712000554 · Cited by 123 · see citing works

The association between panic disorder and the L/L genotype of catechol-O-methyltransferase

Woo, J., Yoon, K., Choi, Y., Oh, K.-S., Lee, Y.-S., & Yu, B. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.01.001 · Cited by 120 · see citing works

Frontal EEG asymmetry and symptom response to cognitive behavioral therapy in patients with social anxiety disorder

Moscovitch, D. A., Santesso, D. L., Miskovic, V., McCabe, R. E., Antony, M. M., & Schmidt, L. A. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.04.009 · Cited by 120 · see citing works

Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorder

Perna, G., Cocchi, S., Bertani, A., Arancio, C., & Bellodi, L. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.623 · Cited by 119 · see citing works

Single-Subject Anxiety Treatment Outcome Prediction using Functional Neuroimaging

Ball, T. M., Stein, M. B., Ramsawh, H. J., Campbell‐Sills, L., & Paulus, M. P. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.328 · Cited by 116 · see citing works

Clinical and genetic outcome determinants of Internet‐ and group‐based cognitive behavior therapy for social anxiety disorder

Hedman, E., Andersson, E., Ljótsson, B., Andersson, G., Andersson, E., Schalling, M., Lindefors, N., & Rück, C. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01834.x · Cited by 114 · see citing works

Genetic and environmental contributions to social anxiety across different ages: A meta-analytic approach to twin data

Scaini, S., Belotti, R., & Ogliari, A. (2014) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2014.07.002 · Cited by 111 · see citing works

Autonomic arousal in children of parents with and without social anxiety disorder: a high-risk study.

Nikolić, M., de Vente, W., Colonnesi, C., & Bögels, S. (2016) · Journal of Child Psychology and Psychiatry and Allied Disciplines · doi:10.1111/jcpp.12563 · Cited by 109 · see citing works

MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy

Reif, A., Richter, J., Straube, B., Höfler, M., Lueken, U., Gloster, A. T., Weber, H., Domschke, K., Fehm, L., Ströhle, A., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.172 · Cited by 108 · see citing works

Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients

Bankier, B., Barajas, J., Martinez-Rumayor, A., & Januzzi, J. L. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn326 · Cited by 102 · see citing works

Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy

Kobayashi, K., Shimizu, E., Hashimoto, K., Mitsumori, M., Koike, K., Okamura, N., Koizumi, H., Ohgake, S., Matsuzawa, D., Zhang, L., et al. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.010 · Cited by 97 · see citing works

Effect of medication and psychotherapy on heart rate variability in panic disorder

Garakani, A., Martinez, J. M., Aaronson, C. J., Voustianiouk, A., Kaufmann, H., & Gorman, J. M. (2008) · Depression and Anxiety · doi:10.1002/da.20533 · Cited by 97 · see citing works

Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets

Iny, L. J., Pecknold, J. C., Suranyi-Cadotte, B. E., Bernier, B., Luthe, L., Nair, N. P. V., & Meaney, M. J. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90625-4 · Cited by 96 · see citing works

Functional neuroanatomy in panic disorder: Status quo of the research

Sobanski, T., & Wagner, G. (2017) · World Journal of Psychiatry · doi:10.5498/wjp.v7.i1.12 · Cited by 96 · see citing works

Antipanic Efficacy of Paroxetine and Polymorphism within the Promoter of the Serotonin Transporter Gene

Perna, G., Favaron, E., Bella, D. D., Bussi, R., & Bellodi, L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300822 · Cited by 95 · see citing works

Noradrenergic function in generalized anxiety disorder: Effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

Charney, D. S., Woods, S. W., & Heninger, G. R. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90132-7 · Cited by 94 · see citing works

Do Unexpected Panic Attacks Occur Spontaneously?

Meuret, A. E., Rosenfield, D., Wilhelm, F. H., Zhou, E., Conrad, A., Ritz, T., & Roth, W. T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.027 · Cited by 92 · see citing works

Extinction of panicogenic effects of a 35% CO₂ challenge in patients with panic disorder.

Schmidt, N. B., Trakowski, J. H., & Staab, J. P. (1997) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.106.4.630 · Cited by 88 · see citing works

Predictors of Response to Pharmacotherapy in Social Anxiety Disorder

Stein, D. J., Stein, M. B., Pitts, C. D., Kumar, R., & Hunter, B. N. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0211 · Cited by 88 · see citing works

Epigenetic signature of panic disorder: A role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation?

Domschke, K., Tidow, N., Schrempf, M., Schwarte, K., Klauke, B., Reif, A., Kersting, A., Arolt, V., Zwanzger, P., & Deckert, J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.014 · Cited by 87 · see citing works

Changes in EEG Cross-Frequency Coupling During Cognitive Behavioral Therapy for Social Anxiety Disorder

Miskovic, V., Moscovitch, D. A., Santesso, D. L., McCabe, R. E., Antony, M. M., & Schmidt, L. A. (2011) · Psychological Science · doi:10.1177/0956797611400914 · Cited by 86 · see citing works

35% CO2 challenge in panic and mood disorders

Perna, G., Barbini, B., Cocchi, S., Bertani, A., & Gasperini, M. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)00088-q · Cited by 84 · see citing works

Affective neuroimaging in generalized anxiety disorder: an integrated review

Fonzo, G. A., & Etkin, A. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/gfonzo · Cited by 84 · see citing works

Cytokine alterations in panic disorder: A systematic review

Quagliato, L. A., & Nardi, A. E. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.094 · Cited by 83 · see citing works

CO2-Induced Panic Attacks: A Twin Study

Bellodi, L., Perna, G., Caldirola, D., Arancio, C., Bertani, A., & Bella, D. D. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1184 · Cited by 80 · see citing works

A Double-Blind Randomized Controlled Trial of Augmentation and Switch Strategies for Refractory Social Anxiety Disorder

Pollack, M. H., Ameringen, M. V., Simon, N. M., Worthington, J. W., Hoge, E. A., Keshaviah, A. P., & Stein, M. B. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12101353 · Cited by 78 · see citing works

Neurostructural abnormalities associated with axes of emotion dysregulation in generalized anxiety

Makovac, E., Meeten, F., Watson, D. R., Garfinkel, S. N., Critchley, H., & Ottaviani, C. (2015) · NeuroImage Clinical · doi:10.1016/j.nicl.2015.11.022 · Cited by 76 · see citing works

Social anxiety disorder: a critical overview of neurocognitive research

Cremers, H. R., & Karin Roelofs, A. (2016) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1390 · Cited by 72 · see citing works

Family and high‐risk studies of social anxiety disorder

Merikangas, K. R., Lieb, R., Wïttchen, H., & Avenevoli, S. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s417.5.x · Cited by 70 · see citing works

Meta-analysis of genome-wide association studies for panic disorder in the Japanese population

Otowa, T., Kawamura, Y., Nishida, N., Sugaya, N., Koike, A., Yoshida, E., Inoue, K., Yasuda, S., Nishimura, Y., Liu, X., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.89 · Cited by 68 · see citing works

Childhood Maltreatment Is Associated with Larger Left Thalamic Gray Matter Volume in Adolescents with Generalized Anxiety Disorder

Liao, M., Yang, F., Zhang, Y., He, Z., Song, M., Jiang, T., Li, Z., Lu, S., Wu, W., Su, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071898 · Cited by 68 · see citing works

Baseline respiratory parameters in panic disorder: A meta-analysis

Grassi, M., Caldirola, D., Vanni, G., Guerriero, G., Piccinni, M., Valchera, A., & Perna, G. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.034 · Cited by 68 · see citing works

Evidence-based pharmacotherapy of panic disorder: an update

Batelaan, N. M., Van Balkom, A. J. L. M., & Stein, D. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000800 · Cited by 67 · see citing works

Gray and white matter volume abnormalities in generalized anxiety disorder by categorical and dimensional characterization

Hilbert, K., Pine, D. S., Muehlhan, M., Lueken, U., Steudte‐Schmiedgen, S., & Beesdo‐Baum, K. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.10.009 · Cited by 67 · see citing works

The costs of social anxiety disorder: the role of symptom severity and comorbidities

Stuhldreher, N., Leibing, E., Leichsenring, F., Beutel, M. E., Herpertz, S., Hoyer, J., Konnopka, A., Salzer, S., Strauss, B., Wiltink, J., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.039 · Cited by 63 · see citing works

Epigenetic regulation of the oxytocin receptor is associated with neural response during selective social attention

Puglia, M. H., Connelly, J. J., & Morris, J. P. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0159-x · Cited by 63 · see citing works

Pharmacologic Effect of Imipramine, Paroxetine, and Sertraline on 35% Carbon Dioxide Hypersensitivity in Panic Patients

Bertani, A., Perna, G., Arancio, C., Caldirola, D., & Bellodi, L. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704000-00006 · Cited by 62 · see citing works

Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety

Molendijk, M. L., Bus, B. A. A., Spinhoven, P., Penninx, B. W. J. H., Prickaerts, J., Oude Voshaar, R. C., & Elzinga, B. M. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.587892 · Cited by 62 · see citing works

Epigenome-wide association study of DNA methylation in panic disorder

Shimada-Sugimoto, M., Otowa, T., Miyagawa, T., Umekage, T., Kawamura, Y., Bundo, M., Iwamoto, K., Tochigi, M., Kasai, K., Kaiya, H., et al. (2017) · Clinical Epigenetics · doi:10.1186/s13148-016-0307-1 · Cited by 61 · see citing works

Panic disorder: from respiration to the homeostatic brain

Perna, G., Caldirola, D., & Bellodi, L. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2004.0080.x · Cited by 61 · see citing works

Evaluating gene × psychological risk factor effects in the pathogenesis of anxiety: A new model approach.

Schmidt, N. B., Storey, J. M., Greenberg, B. D., Santiago, H. T., Li, Q., & Murphy, D. L. (2000) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.109.2.308 · Cited by 61 · see citing works

Brainstem response to hypercapnia: A symptom provocation study into the pathophysiology of panic disorder

Goossens, L., Leibold, N., Peeters, R., Esquivel, G., Knuts, I., Backes, W., Marcelis, M., Hofman, P., Griez, E., & Schruers, K. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114527363 · Cited by 61 · see citing works

Panic Attacks in an Individual With Bilateral Selective Lesions of the Amygdala

Wiest, G., Lehner-Baumgartner, E., & Baumgartner, C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1798 · Cited by 60 · see citing works

Reduced Lymphocyte Proliferation and Interleukin-2 Production in Anxiety Disorders

Koh, K. B., & Lee, B. K. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199807000-00015 · Cited by 60 · see citing works

Childhood trauma in adults with social anxiety disorder and panic disorder: a cross-national study

Löchner, C., Seedat, S., Allgulander, C., Kidd, M., Stein, D. J., & Gerdner, A. (2011) · African Journal of Psychiatry · doi:10.4314/ajpsy.v13i5.63103 · Cited by 58 · see citing works

Carbon Dioxide Hypersensitivity in Separation-Anxious Offspring of Parents with Panic Disorder

Roberson‐Nay, R., Klein, D. F., KLEIN, R. G., Mannuzza, S., Moulton, J. L., Guardino, M., & Pine, D. S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.014 · Cited by 58 · see citing works

Neurobiological correlates of social anxiety disorder: an update

Marazziti, D., Abelli, M., Baroni, S., Carpita, B., Ramacciotti, C., & Dell’Osso, L. (2014) · CNS Spectrums · doi:10.1017/s109285291400008x · Cited by 57 · see citing works

PLASMA OXYTOCIN IMMUNOREACTIVE PRODUCTS AND RESPONSE TO TRUST IN PATIENTS WITH SOCIAL ANXIETY DISORDER

Hoge, E. A., Lawson, E. A., Metcalf, C. A., Keshaviah, A. P., Zak, P. J., Pollack, M. H., & Simon, N. M. (2012) · Depression and Anxiety · doi:10.1002/da.21973 · Cited by 56 · see citing works

A twin study of the common vulnerability between heightened sensitivity to hypercapnia and panic disorder

Battaglia, M., Pesenti‐Gritti, P., Spatola, C. A. M., Ogliari, A. L., & Tambs, K. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30647 · Cited by 55 · see citing works

Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism

Yevtushenko, O. O., Oros, M. M., & Reynolds, G. P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.09.007 · Cited by 54 · see citing works

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder

Lohoff, F. W., Aquino, T. D., Narasimhan, S., Multani, P. K., Etemad, B., & Rickels, K. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.47 · Cited by 53 · see citing works

Neuroimaging Predictors and Mechanisms of Treatment Response in Social Anxiety Disorder: an Overview of the Amygdala

Klumpp, H., & Fitzgerald, J. M. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0948-1 · Cited by 53 · see citing works

CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder?

Schartner, C., Ziegler, C., Schiele, M. A., Kollert, L., Weber, H., Zwanzger, P., Arolt, V., Pauli, P., Deckert, J., Reif, A., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.01.005 · Cited by 53 · see citing works

BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder

Wang, Y., Zhang, H., Li, Y., Wang, Z., Fan, Q., Yu, S., Lin, Z., & Xiao, Z. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.023 · Cited by 50 · see citing works

Genetic moderation of CO 2 -induced fear by 5-HTTLPR genotype

Schruers, K. R. J., Esquivel, G., van Duinen, M. A., Wichers, M., Kenis, G., Colasanti, A., Knuts, I., Goossens, L., Jacobs, N., van Rozendaal, J., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110372543 · Cited by 50 · see citing works

NEUROCIRCUITRY UNDERLYING RISK AND RESILIENCE TO SOCIAL ANXIETY DISORDER

Clauss, J. A., Avery, S. N., VanDerKlok, R. M., Rogers, B. P., Cowan, R. L., Benningfield, M. M., & Blackford, J. U. (2014) · Depression and Anxiety · doi:10.1002/da.22265 · Cited by 50 · see citing works

Modification of 35% Carbon Dioxide Hypersensitivity Across One Week of Treatment With Clomipramine and Fluvoxamine

Perna, G., Bertani, A., Gabriele, A., Politi, E., & Bellodi, L. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00006 · Cited by 50 · see citing works

Behavioral and EEG responses to social evaluation: A two-generation family study on social anxiety

Harrewijn, A., van der Molen, M. J. W., van Vliet, I. M., Tissier, R., & Westenberg, P. M. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.11.010 · Cited by 50 · see citing works

Antipanic Drug Modulation Of 35% CO2 Hyperreactivity and Short-Term Treatment Outcome

Perna, G., Bertani, A., Caldirola, D., Gabriele, A., Cocchi, S., & Bellodi, L. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00011 · Cited by 48 · see citing works

The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder

Moreira, F. P., Fabião, J. D., Bittencourt, G., Wiener, C. D., Jansen, K., Oses, J. P., Quevedo, L. D. Á., Souza, L. D. D. M., Crispim, D., Portela, L. V., et al. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000097 · Cited by 48 · see citing works

Single dose testosterone administration alleviates gaze avoidance in women with Social Anxiety Disorder

Enter, D., Terburg, D., Harrewijn, A., Spinhoven, P., & Karin Roelofs, A. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.008 · Cited by 47 · see citing works

Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population.

Kim, W., choi, Y. H., Yoon, K.-S., Cho, D., Pae, C., & Woo, J. (2006) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.017 · Cited by 46 · see citing works

Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder

Maron, E., Tõru, I., Must, A., Tasa, G., Toover, E., Vasar, V., Lang, A., & Shlik, J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.060 · Cited by 44 · see citing works

A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam

Nardi, A. E., Valença, A. M., Nascimento, I., Lopes, F. L., Mezzasalma, M. A., Freire, R. C. R., Veras, A. B., Zin, W. A., & Versiani, M. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2005.05.011 · Cited by 44 · see citing works

Neuroimaging predictors of treatment response in anxiety disorders

Shin, L. M., Davis, F. C., VanElzakker, M. B., Dahlgren, M. K., & Dubois, S. J. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-15 · Cited by 44 · see citing works

Neural responses to reward in childhood: relations to early behavioral inhibition and social anxiety

Lahat, A., Benson, B. E., Pine, D. S., Fox, N. A., & Monique Ernst, D. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw122 · Cited by 44 · see citing works

Sensitivity to 35% Carbon Dioxide in Patients With Generalized Anxiety Disorder

Perna, G., Bussi, R., Allevi, L., & Bellodi, L. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0606 · Cited by 44 · see citing works

Genetic Polymorphisms in Monoamine Systems and Outcome of Cognitive Behavior Therapy for Social Anxiety Disorder

Andersson, E., Rück, C., Lavebratt, C., Hedman, E., Schalling, M., Lindefors, N., Eriksson, E., Carlbring, P., Andersson, G., & Furmark, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079015 · Cited by 43 · see citing works

Personalized medicine: Prediction of disease vulnerability in mood disorders

Prendes-Alvarez, S., & Nemeroff, C. B. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.09.049 · Cited by 42 · see citing works

Effects of oxytocin on attention to emotional faces in healthy volunteers and highly socially anxious males

Clark-Elford, R., Nathan, P. J., Auyeung, B., Mogg, K., Bradley, B. P., Sule, A., Müller, U., Dudas, R. B., Sahakian, B. J., & Baron-Cohen, S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu012 · Cited by 41 · see citing works

Blushing propensity in social anxiety disorder: influence of serotonin transporter gene variation

Domschke, K., Stevens, S., Beck, B., Baffa, A., Hohoff, C., Deckert, J., & Gerlach, A. L. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0090-z · Cited by 40 · see citing works

Evidence that decreased function of lymphocyte beta adrenoreceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia

Maddock, R. J., Carter, C. S., Magliozzi, J. R., & Gietzen, D. W. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1219 · Cited by 40 · see citing works

Smaller volumes in the lateral and basal nuclei of the amygdala in patients with panic disorder

Asami, T., Nakamura, R., Takaishi, M., Yoshida, H., Yoshimi, A., Whitford, T. J., & Hirayasu, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207163 · Cited by 40 · see citing works

Decreased chaos of heart rate time series in children of patients with panic disorder

Srinivasan, K., Ashok, M. V., Vaz, M. A. P., & Yeragani, V. K. (2002) · Depression and Anxiety · doi:10.1002/da.10046 · Cited by 38 · see citing works

Excess costs of social anxiety disorder in Germany

Dams, J., König, H., Bleibler, F., Hoyer, J., Wiltink, J., Beutel, M. E., Salzer, S., Herpertz, S., Willutzki, U., Strauss, B. M., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.01.041 · Cited by 38 · see citing works

Modulation of Hyperreactivity to 35% CO2 After One Week of Treatment With Paroxetine and Reboxetine: A Double-Blind, Randomized Study

Perna, G., Bertani, A., Caldirola, D., Di Pasquale, D., Migliarese, G., & Bellodi, L. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125682.97466.3c · Cited by 37 · see citing works

Are Respiratory Abnormalities Specific for Panic Disorder? A Meta-Analysis

Grassi, M., Caldirola, D., Chiaro, N. V. D., Riva, A., Daccò, S., Pompili, M., & Perna, G. (2014) · Neuropsychobiology · doi:10.1159/000364830 · Cited by 37 · see citing works

Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder

Furmark, T., Marteinsdóttir, Í., Frick, A., Heurling, K., Tillfors, M., Appel, L., Antoni, G., Hartvig, P., Fischer, H., Långström, B., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116648317 · Cited by 37 · see citing works

Bumping heart and sweaty palms: physiological hyperarousal as a risk factor for child social anxiety

Nikolić, M., Aktar, E., Bögels, S. M., Colonnesi, C., & de Vente, W. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12813 · Cited by 37 · see citing works

Social anxiety disorder in children and youth: A research update on aetiological factors

Elizabeth, J., King, N. J., Ollendick, T. H., Gullone, E., Tonge, B. J., Watson, S., & MacDermott, S. (2006) · Counselling Psychology Quarterly · doi:10.1080/09515070600811790 · Cited by 36 · see citing works

Serotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder

Hernández, E., Lastra, S. D. L., Urbina, M., Carreira, I., & Lima, L. B. Q. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00025-5 · Cited by 36 · see citing works

Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome

Gurguis, G. N. M., Vo, S. P., Griffith, J. M., & Rush, A. J. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00103-1 · Cited by 35 · see citing works

Neuroimaging findings as predictors of treatment outcome of psychotherapy in anxiety disorders

Santos, V. A., Carvalho, D. D., Van Ameringen, M., Nardi, A. E., & Freire, R. C. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.001 · Cited by 34 · see citing works

Influence of RGS2 on Sertraline Treatment for Social Anxiety Disorder

Stein, M. B., Keshaviah, A. P., Haddad, S. A., Ameringen, M. V., Simon, N. M., Pollack, M. H., & Smoller, J. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.301 · Cited by 34 · see citing works

Cerebrospinal fluid levels of monoamine metabolites in panic disorder

Eriksson, E., Westberg, P., Alling, C., Thuresson, K., & Modigh, K. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90023-i · Cited by 33 · see citing works

Abnormalities in gray and white matter volumes associated with explicit memory dysfunction in patients with generalized anxiety disorder

Moon, C., & Jeong, G. (2016) · Acta Radiologica · doi:10.1177/0284185116649796 · Cited by 33 · see citing works

Erratum: Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci

Smıth, D. J., Escott‐Price, V., Davies, G. E., Bailey, M. E. S., Colodro‐Conde, L., Ward, J., Vedernikov, A., Marioni, R. E., Cullen, B., Lyall, D. M., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.177 · Cited by 33 · see citing works

Novel investigational therapeutics for panic disorder

Perna, G., Schruers, K. R. J., Alciati, A., & Caldirola, D. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.996286 · Cited by 32 · see citing works

The 35% CO 2 Hyperreactivity and Clinical Symptomatology in Patients With Panic Disorder After 1 Week of Treatment With Citalopram: An Open Study

Bertani, A., Caldirola, D., Bussi, R., Bellodi, L., & Perna, G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00003 · Cited by 32 · see citing works

Pretreatment Cardiac Vagal Tone Predicts Dropout from and Residual Symptoms after Exposure Therapy in Patients with Panic Disorder and Agoraphobia

Wendt, J., Hamm, A. O., Pané‐Farré, C. A., Thayer, J. F., Gerlach, A. L., Gloster, A. T., Lang�, T., Helbig‐Lang, S., Pauli, P., Fydrich, T., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000487599 · Cited by 32 · see citing works

Panic disorder and immunity: Few effects on circulating lymphocytes, mitogen response, and NK cell activity

Schleifer, S. J., Keller, S. E., & Bartlett, J. A. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00022-3 · Cited by 31 · see citing works

Anxiety Disorder-Specific Predictors of Treatment Outcome in the Coordinated Anxiety Learning and Management (CALM) Trial

Jakubovski, E., & Bloch, M. H. (2016) · Psychiatric Quarterly · doi:10.1007/s11126-015-9399-6 · Cited by 31 · see citing works

The norepinephrine transporter gene is a candidate gene for panic disorder

Buttenschøn, H. N., Kristensen, A. S., Buch, H. N., Andersen, J. H., Bonde, J. P., Grynderup, M. B., Hansen, Å. M., Kolstad, H. A., Kærgaard, A., Kærlev, L., et al. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0624-7 · Cited by 30 · see citing works

Changes in gray matter volume of remitted first-episode, drug-naïve, panic disorder patients after 6-week antidepressant therapy

Lai, C., & Wu, Y. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.09.013 · Cited by 30 · see citing works

Norepinephrine transporter gene (NET) variants in patients with panic disorder

Sand, P. G., Mori, T., Godau, C., Stöber, G., Flachenecker, P., Franke, P. E., Nöthen, M. M., Fritze, J., Maier, W., Lesch, K., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00984-9 · Cited by 30 · see citing works

Improvements in white matter micro-structural integrity of right uncinate fasciculus and left fronto-occipital fasciculus of remitted first-episode medication-naïve panic disorder patients

Lai, C., Wu, Y., Yu, P.-L., & Yuan, W. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.014 · Cited by 30 · see citing works

Biological and Clinical Markers in Panic Disorder

Cosci, F., & Mansueto, G. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.07.26 · Cited by 30 · see citing works

Testing the diathesis‐stress model: 5‐HTTLPR, childhood emotional maltreatment, and vulnerability to social anxiety disorder

Reinelt, E., Stopsack, M., Aldinger, M., John, U., Grabe, H. J., & Barnow, S. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32142 · Cited by 28 · see citing works

Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder

Narasimhan, S., Aquino, T. D., Multani, P. K., Rickels, K., & Lohoff, F. W. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.034 · Cited by 28 · see citing works

Major depressive disorder, generalised anxiety disorder, and their comorbidity: Associations with cortisol in the Vietnam Experience Study

Phillips, A. C., Batty, G. D., Galé, C. R., Lord, J. M., Arlt, W., & Carroll, D. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.011 · Cited by 28 · see citing works

Respiration in Children at Risk for Panic Disorder

Perna, G., Ieva, A., Caldirola, D., Bertani, A., & Bellodi, L. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.2.185 · Cited by 27 · see citing works

Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response

Slaap, B. R. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(96)00013-4 · Cited by 26 · see citing works

Association between amygdala reactivity and a dopamine transporter gene polymorphism

Bergman, O., Åhs, F., Furmark, T., Appel, L., Linnman, C., Faria, V., Bani, M., Pich, E. M., Bettica, P. U., Henningsson, S., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.50 · Cited by 26 · see citing works

Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls

Engel, K. R., Obst, K. U., Bandelow, B., Dechent, P., Gruber, O., Zerr, I., Ulrich, K., & Wedekind, D. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0653-6 · Cited by 26 · see citing works

Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder

Cooper, A. J., Narasimhan, S., Rickels, K., & Lohoff, F. W. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.07.038 · Cited by 25 · see citing works

Panic and the Brainstem: Clues from Neuroimaging Studies

Perna, G., Guerriero, G., Brambilla, P., & Caldirola, D. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140612112923 · Cited by 24 · see citing works

Brain-derived neurotrophic factor serum levels in genetically isolated populations: gender-specific association with anxiety disorder subtypes but not with anxiety levels or Val66Met polymorphism

Carlino, D., Francavilla, R., Baj, G., Kulak, K., d’Adamo, P., Ulivi, S., Cappellani, S., Gasparini, P., & Tongiorgi, E. (2015) · PeerJ · doi:10.7717/peerj.1252 · Cited by 23 · see citing works

Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder

Narasimhan, S., Aquino, T. D., Hodge, R., Rickels, K., & Lohoff, F. W. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.08.035 · Cited by 23 · see citing works

Personalized Medicine in Psychiatry: Back to the Future

Perna, G., & Nemeroff, C. B. (2017) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2017.01.001 · Cited by 22 · see citing works

Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder: a preliminary study

Slaap, B. R., Boshuisen, M. L., van Roon, A. M., & den Boer, J. A. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200203000-00005 · Cited by 20 · see citing works

BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data

Pallanti, S., Tofani, T., Zanardelli, M., Mannelli, L. D. C., & Ghelardini, C. (2014) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2014.940051 · Cited by 20 · see citing works

Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder

Perna, G., Bella, D. D., Favaron, E., Cucchi, M., Liperi, L., & Bellodi, L. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30035 · Cited by 20 · see citing works

Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder

Ishiguro, S., Watanabe, T., Ueda, M., Saeki, Y., Hayashi, Y., Akiyama, K., Saito, A., Kato, K., Inoue, Y., & Shimoda, K. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1073-9 · Cited by 20 · see citing works

Neuroendocrine models of social anxiety disorder

van Honk, J., Bos, P. A., Terburg, D., Heany, S. J., & Stein, D. J. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/jhonk · Cited by 20 · see citing works

Affective Neural Responses Modulated by Serotonin Transporter Genotype in Clinical Anxiety and Depression

Oathes, D. J., Hilt, L. M., & Nitschke, J. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115820 · Cited by 19 · see citing works

A neuromarker of clinical outcome in attention bias modification therapy for social anxiety disorder

Arad, G., Abend, R., Pine, D. S., & Bar‐Haim, Y. (2018) · Depression and Anxiety · doi:10.1002/da.22858 · Cited by 18 · see citing works

Lack of influence ofDAT1andDRD2gene variants on antidepressant response in generalized anxiety disorder

Saung, W. T., Narasimhan, S., & Lohoff, F. W. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2404 · Cited by 17 · see citing works

Is panic disorder a disorder of physical fitness? A heuristic proposal

Perna, G., & Caldirola, D. (2018) · F1000Research · doi:10.12688/f1000research.12788.1 · Cited by 17 · see citing works

Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder

Saeki, Y., Watanabe, T., Ueda, M., Saito, A., Akiyama, K., Inoue, Y., Hirokane, G., Morita, S., Yamada, N., & Shimoda, K. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0633-8 · Cited by 16 · see citing works

β-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder

Lee, I.-S., Kim, K.-J., Kang, E., & Yu, B. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.12.007 · Cited by 15 · see citing works

Exogenous testosterone affects early threat processing in socially anxious and healthy women.

van Peer, J. V., Enter, D., van Steenbergen, H., Spinhoven, P., & Roelofs, K. (2017) · Biological Psychology · doi:10.1016/j.biopsycho.2017.08.003 · Cited by 13 · see citing works

Low pre-treatment end-tidal CO 2 predicts dropout from cognitive-behavioral therapy for anxiety and related disorders

Tolin, D. F., Billingsley, A. L., Hallion, L. S., & Diefenbach, G. J. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.12.005 · Cited by 12 · see citing works

Social anxiety disorder has social and economic burden

Nardi, A. E. (2003) · BMJ · doi:10.1136/bmj.327.7426.1287-a · Cited by 11 · see citing works

Phosphate levels as a possible state marker in panic disorder: preliminary study of a feasible laboratory measure for routine clinical practice

Pérez-Costillas, L., Montes, M. R., Martínez-Ortega, J. M., Carretero, M. D., Gutiérrez-Rojas, L., & Manuel Gurpegui, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.022 · Cited by 9 · see citing works

When change is the only constant: The promise of longitudinal neuroimaging in understanding social anxiety disorder

Haller, S. P., Mills, K. L., Hartwright, C. E., David, A. S., & Kadosh, K. C. (2018) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2018.05.005 · Cited by 9 · see citing works

Hypophosphatemia in Panic Disorder

Roestel, C., Höping, W., & Deckert, J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1499-a · Cited by 9 · see citing works

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

Aoki, A., Watanabe, T., Ishiguro, S., Hayashi, Y., Akiyama, K., Kato, K., Inoue, Y., Tsuchimine, S., Yasui‐Furukori, N., Shimoda, K., et al. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s68670 · Cited by 6 · see citing works

Association Analysis of the Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Gender with Efficacy of Antidepressants in the Chinese Han Population with Generalized Anxiety Disorder

Lin, M., Zhu, J., Yuan, Y., Ren, L., Qian, M., Shen, Z., Shao, Y., & Shen, X. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2017.0053 · Cited by 6 · see citing works

Red Blood Cell and Platelet Indices: A Potential Biomarker for Panic Disorder

Bhad, R. (2017) · Journal of Neurosciences in Rural Practice · doi:10.4103/jnrp.jnrp_33_17 · Cited by 5 · see citing works

Respiratory subtype of panic disorder: Can serum phosphate levels be a possible outcome to group cognitive-behavior therapy?

Beria, P., Viana, A. C. W., Behenck, A. D. S., Heldt, E., Manfro, G. G., & Dreher, C. B. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.002 · Cited by 4 · see citing works

Candidate biomarkers in psychiatric disorders: state of the field

Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 390 · see citing works

Review of EEG, ERP, and Brain Connectivity Estimators as Predictive Biomarkers of Social Anxiety Disorder

Al-Ezzi, A., Kamel, N., Faye, I., & Gunaseli, E. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00730 · Cited by 97 · see citing works

The benefits of hesperidin in central nervous system disorders, based on the neuroprotective effect

Li, X., Huang, W., Tan, R., Xu, C., Chen, X., Li, S., Liu, Y., Qiu, H., Cao, H., & Cheng, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114222 · Cited by 87 · see citing works

Cluster-based psychological phenotyping and differences in anxiety treatment outcomes

Taylor, V. A., Roy, A., & Brewer, J. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-28660-7 · Cited by 11 · see citing works

A Lupin (Lupinus angustifolius) Protein Hydrolysate Exerts Anxiolytic-Like Effects in Western Diet-Fed ApoE−/− Mice

Santos‐Sánchez, G., Ponce‐España, E., López, J. C., Álvarez‐Sánchez, N., Álvarez‐López, A. I., Pedroche, J., Millán, F., Millán-Linares, M. C., Lardone, P. J., Bejarano, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179828 · Cited by 11 · see citing works

‘Precision’ or ‘personalized’ psychiatry: different terms – same content?

Perna, G., Cuniberti, F., Daccò, S., Grassi, M., & Caldirola, D. (2020) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1211-2722 · Cited by 8 · see citing works

Drug repurposing for personalized medicine

Hora, J., Rambhia, N., & Mani, I. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.02.007 · Cited by 3 · see citing works

Chapter 8. Personalized Medicine in Psychiatry

Perna, G., Alciati, A., & Nemeroff, C. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as08 · Cited by 2 · see citing works

Possibilities of Personalized Selection of Psychotherapy for Comorbid Depressive and Stressful Disorders, Targets of Cognitive Behavioral Therapy (CBT) and Person-Centered (Reconstructive) Psychotherapy (LORP)

Андреевна, С. Д., Vasileva, A. V., Караваева, Т. А., Ляшковская, С. В., & Andrianova, A. E. (2025) · Psikhiatriya · doi:10.30629/2618-6667-2025-23-3-111-122 · Cited by 1 · see citing works

The Use of Gamification in Social Phobia

Simões-Silva, V., Maravalhas, V., Cunha, A. R., Soares, M. I., & Marques, A. J. (2020) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-7472-0.ch009 · Cited by 1 · see citing works

The Chongqing Adolescent Twin Study: An Integrative Multimodal Brain Imaging and Non-imaging Dataset

Zhu, Y., Fu, Y., Han, J., Wang, R., Ma, X., Hu, X., Li, T., & Ma, Z. (2025) · Scientific Data · doi:10.1038/s41597-025-05449-z · Cited by 1 · see citing works

FEATURES OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH FUNCTIONAL INTESTINAL DISORDERS

Kryvoruchko, I. G., Skrypnyk, І. М., Приходько, Н. П., Scherbak, О. В., & Yakimishina, L. I. (2021) · Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії · doi:10.31718/2077-1096.21.4.43

The Use of Gamification in Social Phobia

Simões-Silva, V., Maravalhas, V., Cunha, A. R., Soares, M. I., & Marques, A. J. (2022) · IGI Global eBooks · doi:10.4018/978-1-6684-7589-8.ch060

Pharmacological approaches to the management of panic disorder in older patients: a systematic review

Caldirola, D., Donatis, D. D., Alciati, A., Daccò, S., & Perna, G. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2254938

Effects of metformin in an experimental chronic unpredictable mild stress model

Ozsagır, M. H., Polat, E. B., Kaya, Ö. T. Ç., Aykaç, A., & Özbeyli, D. (2026) · Journal of Research in Pharmacy · doi:10.12991/jrespharm.1690442

Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application

Lueken, U., Zierhut, K. C., Hahn, T., Straube, B., Kircher, T., Reif, A., Richter, J., Hamm, A., Wittchen, H.-U., & Domschke, K. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.005 · Cited by 133 · see citing works

Personalized Medicine Approaches in the Treatment Of Mental Health Disorder

Swapnil D. Aade, Z. M. S. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.14541704

Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs

Roseberry, K., Le-Niculescu, H., Levey, D. F., Bhagar, R., Soe, K. C., Rogers, J., Palkowitz, S., Piña, N. N., Anastasiadis, W. A., Gill, S., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01998-0 · Cited by 31 · see citing works

Anxiety Disorders

Piccoli, E., Vanzetto, S., Cerolini, L., Conti, D., Celebre, L., & Dell’Osso, B. M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.019

Biological predictors of pharmacological therapy in anxiety disorders

Maron, E., & Nutt, D. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/emaron · Cited by 24 · see citing works